HUmira in Psoriatic Arthritis
Launched by GLOSTRUP UNIVERSITY HOSPITAL, COPENHAGEN · Nov 3, 2011
Trial Information
Current as of June 15, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Subject Population: patients with active PsA, fulfilling the following major criteria:
- • 1. Diagnosis of PsA according to Moll and Wright criteria (Moll and Wright,
- • 2. Clinical active disease, defined as \>2 (of 76) swollen joints and \> 2 (of 78) tender joints
- • 3. Involvement of the hands (Clinical swelling of 1 or more finger joint and/or 1 or more 1 sausage finger)
- • 4. Clinical indication for anti-TNF alpha therapy, according to treating physician
- • 5. Among other issues: Age \>18 years; adequate birth control; no contraindications for anti-TNF alpha-therapy, no previous anti-TNF alpha-therapy, no other significant dermatological disorders than psoriasis.
About Glostrup University Hospital, Copenhagen
Glostrup University Hospital, located in Copenhagen, is a leading clinical research institution renowned for its commitment to advancing medical science and patient care through innovative clinical trials. As a part of the Copenhagen University Hospital network, it integrates cutting-edge research with comprehensive healthcare services, focusing on a wide range of medical disciplines. The hospital fosters collaborative partnerships with academic institutions and industry stakeholders to facilitate the development of new therapies and interventions, ensuring rigorous adherence to ethical standards and regulatory guidelines. With a dedicated team of experienced clinicians and researchers, Glostrup University Hospital is at the forefront of translating research findings into practical treatments that enhance patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glostrup, Copenhagen, Denmark
Patients applied
Trial Officials
Charlotte Wiell, MD, PhD
Study Chair
University Hospital, Gentofte, Copenhagen
Inge Juul Sørensen, MD, PhD
Principal Investigator
Copenhagen University Hospital, Hvidovre
Michael Sejer Hansen, MD, PhD
Principal Investigator
Copenhagen University Hospital at Herlev
Ole Rintek Madsen, MD, PhD
Principal Investigator
University Hospital, Gentofte, Copenhagen
Ole Slot, MD
Principal Investigator
Glostrup University Hospital, Copenhagen
Susanne J Pedersen, MD
Principal Investigator
Gentofte University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials